295 related articles for article (PubMed ID: 16234694)
1. Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients.
Morgenstern KE; Vadysirisack DD; Zhang Z; Cahill KV; Foster JA; Burns JA; Kloos RT; Jhiang SM
Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):337-44. PubMed ID: 16234694
[TBL] [Abstract][Full Text] [Related]
2. Relationship between radioactive iodine therapy for thyroid carcinoma and nasolacrimal drainage system obstruction.
Cetinkaya A; Kersten RC
Ophthalmic Plast Reconstr Surg; 2007; 23(6):496. PubMed ID: 18030131
[No Abstract] [Full Text] [Related]
3. Characterization of mucins in human lacrimal sac and nasolacrimal duct.
Paulsen FP; Corfield AP; Hinz M; Hoffmann W; Schaudig U; Thale AB; Berry M
Invest Ophthalmol Vis Sci; 2003 May; 44(5):1807-13. PubMed ID: 12714609
[TBL] [Abstract][Full Text] [Related]
4. [Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma].
Fonseca FL; Lunardelli P; Matayoshi S
Arq Bras Oftalmol; 2012; 75(2):97-100. PubMed ID: 22760799
[TBL] [Abstract][Full Text] [Related]
5. Nasolacrimal obstruction secondary to I(131) therapy.
Burns JA; Morgenstern KE; Cahill KV; Foster JA; Jhiang SM; Kloos RT
Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):126-9. PubMed ID: 15083081
[TBL] [Abstract][Full Text] [Related]
6. Nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma.
Shepler TR; Sherman SI; Faustina MM; Busaidy NL; Ahmadi MA; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2003 Nov; 19(6):479-81. PubMed ID: 14625496
[TBL] [Abstract][Full Text] [Related]
7. Altered Surfactant Protein Expression in Primary Acquired Nasolacrimal Duct Obstruction.
Ali MJ; Bráuer L; Schicht M; Paulsen F
Ophthalmic Plast Reconstr Surg; 2019; 35(6):553-557. PubMed ID: 30882588
[TBL] [Abstract][Full Text] [Related]
8. Update on lacrimal apparatus dysfunction associated with differentiated thyroid cancer after I-131 therapy.
Liang C; Wu C; Liu L; Zhong J
Int Ophthalmol; 2024 Jun; 44(1):257. PubMed ID: 38909080
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic study of lacrimal sac and nasal mucosa in 44 patients with complete acquired nasolacrimal duct obstruction.
Mauriello JA; Palydowycz S; DeLuca J
Ophthalmic Plast Reconstr Surg; 1992; 8(1):13-21. PubMed ID: 1554647
[TBL] [Abstract][Full Text] [Related]
10. TFF peptides in the human efferent tear ducts.
Paulsen FP; Hinz M; Schaudig U; Thale AB; Hoffmann W
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3359-64. PubMed ID: 12407144
[TBL] [Abstract][Full Text] [Related]
11. Qualitative Hormonal Profiling of the Lacrimal Drainage System: Potential Insights into the Etiopathogenesis of Primary Acquired Nasolacrimal Duct Obstruction.
Ali MJ; Schicht M; Paulsen F
Ophthalmic Plast Reconstr Surg; 2017; 33(5):381-388. PubMed ID: 28759505
[TBL] [Abstract][Full Text] [Related]
12. Clinically suspected primary acquired nasolacrimal duct obstruction: clinicopathologic review of 150 patients.
Tucker N; Chow D; Stockl F; Codère F; Burnier M
Ophthalmology; 1997 Nov; 104(11):1882-6. PubMed ID: 9373121
[TBL] [Abstract][Full Text] [Related]
13. Acquired nasolacrimal duct obstruction: clinical and histological findings of 275 cases.
Makselis A; Petroska D; Kadziauskiene A; Jaruseviciene R; Ruzgys A; Cimbalas A; Besusparis J; Asoklis RS
BMC Ophthalmol; 2022 Jan; 22(1):12. PubMed ID: 34986808
[TBL] [Abstract][Full Text] [Related]
14. Detection and localization of the hydrophobic surfactant proteins B and C in human tear fluid and the human lacrimal system.
Bräuer L; Johl M; Börgermann J; Pleyer U; Tsokos M; Paulsen FP
Curr Eye Res; 2007 Nov; 32(11):931-8. PubMed ID: 18027169
[TBL] [Abstract][Full Text] [Related]
15. MUC16 in the lacrimal apparatus.
Jäger K; Wu G; Sel S; Garreis F; Bräuer L; Paulsen FP
Histochem Cell Biol; 2007 Apr; 127(4):433-8. PubMed ID: 17211626
[TBL] [Abstract][Full Text] [Related]
16. Aquaporin expression in the lacrimal sac of patients with primary and functional nasolacrimal duct obstruction.
Park J; Kim J; Kim M; Baek S
Br J Ophthalmol; 2017 Apr; 101(4):519-524. PubMed ID: 27439740
[TBL] [Abstract][Full Text] [Related]
17. Nasal and Lacrimal Sac Histopathology in Patients With Granulomatous Polyangiitis Undergoing Lacrimal Drainage Surgery.
Stewart CM; Rose GE
Ophthalmic Plast Reconstr Surg; 2020; 36(1):67-69. PubMed ID: 31593043
[TBL] [Abstract][Full Text] [Related]
18. Na+/I- symporter expression, function, and regulation in non-thyroidal tissues and impact on thyroid cancer therapy.
Jhiang SM; Sipos JA
Endocr Relat Cancer; 2021 Sep; 28(10):T167-T177. PubMed ID: 33974556
[TBL] [Abstract][Full Text] [Related]
19. [A comparative study of lacrimal magnetic resonance hydrography and lacrimal endoscopy examination in the diagnosis and treatment of lacrimal duct obstructive diseases].
Xiang N; Liu R; Zhang SJ; Hu WK; Zhan XY; Luo B; Ai T
Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):117-22. PubMed ID: 26906707
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
